Monday, October 29, 2007
Herman van Barneveld
Paul Lucas, President and CEO of GlaxoSmithKline Inc., is pleased to announce the following appointment:
Mr. Herman van Barneveld has been appointed Vice-President, Finance and Chief Financial Officer of GSK Inc., leading the company’s financial planning and reporting.
Having joined GSK in 1997, Mr. van Barneveld held a number of senior positions within the company, most recently with GSK’s European division where he was Director, Finance & IT. In addition, Mr. van Barneveld was responsible for Corporate Governance and Risk Management, and headed the European Distribution & Supply Chain Program.
Mr. van Barneveld has a degree in Economics from HEAO Utrecht and a CPA from Erasmus University, Rotterdam.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and health-care companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. In Canada, GlaxoSmithKline is among the top 15 investors in research and development, contributing more than $176 million in 2006 alone. GSK is an Imagine Caring Company, and is consistently recognized as one of the 50 Best Employers in Canada.
Back to top